{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CEPI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CEPI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","market":"US","secType":"STK","nameCN":"REX CRYPTO EQUITY PREMIUM INCOME ETF","latestPrice":32.53,"timestamp":1770733940845,"preClose":32.5955,"halted":0,"volume":4090,"delay":0,"changeRate":-0.002009479836173708,"floatShares":2690000,"shares":2690000,"eps":0,"marketStatus":"Trading","change":-0.0655,"latestTime":"02-10 09:32:37 EST","open":32.53,"high":32.53,"low":32.53,"amount":133050.2358,"amplitude":0,"askPrice":32.73,"askSize":400,"bidPrice":32.53,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":32.5955,"sharesOutstanding":2690000,"nav":31.78,"aum":85488200,"dividendRate":0.5119,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":32.61,"preClose":32.5955,"latestTime":"09:29 EST","volume":169,"amount":5510.090196,"timestamp":1770733797065,"change":0.0145,"changeRate":0.000445,"amplitude":0.000307},"postHourTrading":{"tag":"盘后","latestPrice":32.67,"preClose":32.5955,"latestTime":"19:41 EST","volume":53,"amount":1735.873,"timestamp":1770684095862,"change":0.0745,"changeRate":0.002286,"amplitude":0},"volumeRatio":7.446841,"impliedVol":0.2494,"impliedVolPercentile":0.5817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","floatShares":2690000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":7.446841,"shares":2690000,"dividePrice":16.6521,"high":32.53,"amplitude":0,"preClose":32.5955,"low":32.53,"week52Low":29.03,"pbRate":"--","week52High":49.71,"institutionHeld":0,"latestPrice":32.53,"committee":-0.995012,"eps":0,"divideRate":0.5119,"volume":4090,"delay":0,"ttmEps":0,"open":32.53,"prevYearClose":33.6685,"prevWeekClose":31.8029,"prevMonthClose":33.3853,"prevQuarterClose":33.6685,"fiveDayClose":32.8219,"twentyDayClose":35.3557,"sixtyDayClose":38.2131},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEPI\",params:#limit:5,,,undefined,":[{"date":"2026-01-27","symbol":"CEPI","amount":1.2516,"announcedDate":"2026-01-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-27","defaultRemindTime":1769524200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-28","payableDate":"2026-01-27","currency":"USD","dateTimestamp":1769490000000,"payDate":"2026-01-28"},{"date":"2025-12-23","symbol":"CEPI","amount":1.2327,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2025-11-26","symbol":"CEPI","amount":1.22815,"announcedDate":"2025-11-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-26","defaultRemindTime":1764167400000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-26","currency":"USD","dateTimestamp":1764133200000,"payDate":"2025-11-28"},{"date":"2025-10-28","symbol":"CEPI","amount":1.49625,"announcedDate":"2025-10-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-28","defaultRemindTime":1761658200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-29","payableDate":"2025-10-28","currency":"USD","dateTimestamp":1761624000000,"payDate":"2025-10-29"},{"date":"2025-09-23","symbol":"CEPI","amount":1.4385,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEPI\",market:\"US\",,,undefined,":[{"executeDate":"2025-01-28","recordDate":"2025-01-28","paymentDate":"2025-01-29","value":1.69835,"currency":"USD"},{"executeDate":"2025-02-25","recordDate":"2025-02-25","paymentDate":"2025-02-26","value":1.57775,"currency":"USD"},{"executeDate":"2025-03-25","recordDate":"2025-03-25","paymentDate":"2025-03-26","value":1.45915,"currency":"USD"},{"executeDate":"2025-04-29","recordDate":"2025-04-29","paymentDate":"2025-04-30","value":1.3286,"currency":"USD"},{"executeDate":"2025-05-29","recordDate":"2025-05-29","paymentDate":"2025-05-30","value":1.3881,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEPI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CEPI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607773516","title":"SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family","url":"https://stock-news.laohu8.com/highlight/detail?id=2607773516","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607773516?lang=en_us&edition=fundamental","pubTime":"2026-01-29 10:10","pubTimestamp":1769652600,"startTime":"0","endTime":"0","summary":"Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family. Next-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle technology. SK bioscience will continue to strengthen a Mid- to Long-Term global vaccine strategy centered on universal vaccines for future pandemic preparedness. SK bioscience aims to develop a universal vaccine capable of inducing broad immune responses across the entire virus family and is establishing a platform applicable to multiple related viruses and variants.","market":"other","thumbnail":"https://mma.prnewswire.com/media/2872245/Photo_1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2872245/Photo_1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sk-bioscience-initiates-international-phase-12-clinical-trial-of-universal-vaccine-candidate-targeting-sarbecovirus-family-302673365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","IPD.AU","UVV","BK7007","BK4075","CEPI"],"gpt_icon":0},{"id":"2585027438","title":"How Investors May Respond To Cognizant Technology Solutions (CTSH) Securing CEPI’s Digital Transformation Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2585027438","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585027438?lang=en_us&edition=fundamental","pubTime":"2025-11-24 05:18","pubTimestamp":1763932723,"startTime":"0","endTime":"0","summary":"On November 20, 2025, the Coalition for Epidemic Preparedness Innovations (CEPI) announced the selection of Cognizant Technology Solutions to deliver a multi-year digital transformation program, including implementing a new HR and Expense Management System and consolidating support for CEPI's Salesforce platform.\nThis collaboration underscores Cognizant's increasing recognition for expertise in enterprise architecture, platform implementation, and AI-enabled automation in the healthcare and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8031000-choice2-main-header/1585186598236","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8031000-choice2-main-header/1585186598236"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-ctsh/cognizant-technology-solutions/news/how-investors-may-respond-to-cognizant-technology-solutions","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-ctsh/cognizant-technology-solutions/news/how-investors-may-respond-to-cognizant-technology-solutions","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0823417653.USD","LU2087621335.USD","LU2506951958.HKD","LU1048596156.SGD","CTSH","LU1267930656.SGD","BK4211","CEPI","LU0006061336.USD","LU0823417737.USD","LU2506952097.USD","BK4528","LU0072462343.USD","LU0950375773.USD","BK4588","LU1048588211.SGD","BK4023","LU0708995666.HKD","LU2506952170.USD","BK4585","LU0231203729.USD","BK4551","LU0536402901.SGD","AI","LU1839511570.USD","LU0821914370.USD","BK4587","LU2506951875.HKD","BK4134","ISBC","BK4543"],"gpt_icon":0},{"id":"2575784366","title":"Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2575784366","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575784366?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:00","pubTimestamp":1760529600,"startTime":"0","endTime":"0","summary":"Seasoned clinician and R&D leader brings extensive experience in translational medicine, drug development, and infectious disease researchWESTLAKE VILLAGE, Calif., Oct.  15, 2025  (GLOBE NEWSWIRE) -- ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/15/3167031/0/en/Turn-Therapeutics-Appoints-Dr-Kent-Kester-to-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEPI","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}